Test Your Knowledge: Top Findings From AAN 2026

Summary: At the 2026 American Academy of Neurology meeting in Chicago, doctors shared exciting news about brain health. A popular drug called semaglutide was shown to actually lower the risk of adult-onset epilepsy in people with type 2 diabetes. Other big discoveries included a new daily pill for narcolepsy, a four-year study showing eptinezumab works well for chronic migraines, and proof that early treatment with ocrelizumab helps multiple sclerosis patients keep their ability to walk and use their hands. They also checked the safety of a new Alzheimer's pill.

For more details, see Neurology Advisor at neurologyadvisor.com/topics/general-neurology/aan-2026-quiz/ (opens in new tab)